Page last updated: 2024-11-02

pemoline and Behavior Disorders

pemoline has been researched along with Behavior Disorders in 11 studies

Pemoline: A central nervous system stimulant used in fatigue and depressive states and to treat hyperkinetic disorders in children.
pemoline : A member of the class of 1,3-oxazoles that is 1,3-oxazol-4(5H)-one which is substituted by an amino group at position 2 and by a phenyl group at position 5. A central nervous system stimulant, it was used to treat hyperactivity disorders in children, but withdrawn from use following reports of serious hepatotoxicity.

Research Excerpts

ExcerptRelevanceReference
"Those disorders discussed are attention deficit disorder, conduct disorders, anxiety disorders, sleep disorders, schizophrenia, autism, Tourette's syndrome, mental retardation, depressive illness, manic depressive illness, eating disorders, and enuresis."2.37Pharmacologic treatment of psychiatric and neurodevelopmental disorders in children and adolescents (Part 1). ( McDaniel, KD, 1986)
" Often, these agents are used in combination with other medications."1.30Drug interactions with psychostimulants. ( DeVane, CL; Markowitz, JS; Morrison, SD, 1999)

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19904 (36.36)18.7374
1990's4 (36.36)18.2507
2000's1 (9.09)29.6817
2010's2 (18.18)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Devine, DP2
ZGAGA, N1
Holmes, VF1
Biederman, J1
Markowitz, JS1
Morrison, SD1
DeVane, CL1
Homsi, J1
Walsh, D1
Nelson, KA1
Clark, AN1
Warneke, L1
McDaniel, KD1
Chiarello, RJ1
Cole, JO1

Reviews

6 reviews available for pemoline and Behavior Disorders

ArticleYear
Medical use of psychostimulants: an overview.
    International journal of psychiatry in medicine, 1995, Volume: 25, Issue:1

    Topics: Central Nervous System Stimulants; Depressive Disorder; Dextroamphetamine; Drug Interactions; Humans

1995
Attention-deficit/hyperactivity disorder: a life-span perspective.
    The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 7

    Topics: Adolescent; Adult; Age Factors; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hy

1998
Psychostimulants in supportive care.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2000, Volume: 8, Issue:5

    Topics: Adult; Caffeine; Central Nervous System Stimulants; Child; Dextroamphetamine; Ephedrine; Humans; Men

2000
Psychostimulants in psychiatry.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1990, Volume: 35, Issue:1

    Topics: Adult; Depressive Disorder; Dextroamphetamine; Female; Humans; Male; Mental Disorders; Methylphenida

1990
Pharmacologic treatment of psychiatric and neurodevelopmental disorders in children and adolescents (Part 1).
    Clinical pediatrics, 1986, Volume: 25, Issue:2

    Topics: Adolescent; Aggression; Antidepressive Agents; Antipsychotic Agents; Anxiety, Separation; Attention

1986
The use of psychostimulants in general psychiatry. A reconsideration.
    Archives of general psychiatry, 1987, Volume: 44, Issue:3

    Topics: Adult; Amphetamine; Central Nervous System Stimulants; Clinical Trials as Topic; Depressive Disorder

1987

Trials

1 trial available for pemoline and Behavior Disorders

ArticleYear
The use of psychostimulants in general psychiatry. A reconsideration.
    Archives of general psychiatry, 1987, Volume: 44, Issue:3

    Topics: Adult; Amphetamine; Central Nervous System Stimulants; Clinical Trials as Topic; Depressive Disorder

1987

Other Studies

5 other studies available for pemoline and Behavior Disorders

ArticleYear
The Pemoline Model of Self-Injurious Behavior: An Update.
    Methods in molecular biology (Clifton, N.J.), 2019, Volume: 2011

    Topics: Animals; Central Nervous System Stimulants; Disease Models, Animal; Female; Humans; Male; Mental Dis

2019
Animal models of self-injurious behaviour: an overview.
    Methods in molecular biology (Clifton, N.J.), 2012, Volume: 829

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e

2012
[Tradon in psychiatry. With special reference to convalescence states following hypnotic poisoning].
    Wiener medizinische Wochenschrift (1946), 1961, Sep-02, Volume: 111

    Topics: Azoles; Central Nervous System Stimulants; Convalescence; Hypnotics and Sedatives; Mental Disorders;

1961
Drug interactions with psychostimulants.
    International clinical psychopharmacology, 1999, Volume: 14, Issue:1

    Topics: Anticonvulsants; Antidepressive Agents; Antihypertensive Agents; Antipsychotic Agents; Dextroampheta

1999
Morale and motivation.
    The Practitioner, 1978, Volume: 220, Issue:1319

    Topics: Aged; Dextroamphetamine; Diagnosis, Differential; Female; Humans; Male; Mental Disorders; Methylphen

1978